The differential expression of VEGF, VEGFR-2, and GLUT-1 proteins in disease subtypes of systemic sclerosis

Human Pathology

Volumn 37, Issue 2, 2006, Pages 190-197

  Davies, Christine Ann ^a   Jeziorska, Maria ^a   Freemont, Anthony J ^a   Herrick, Ariane L ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b HOPE HOSPITAL   (United Kingdom)

Author keywords

GLUT 1; Immunohistochemistry; Skin; Systemic sclerosis; VEGF

Indexed keywords

GLUCOSE TRANSPORTER 1; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; EPIDERMIS; FEMALE; FIBROBLAST; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; KRUSKAL WALLIS TEST; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; PERICYTE; PROTEIN LOCALIZATION; PUNCH BIOPSY; SKIN BIOPSY; SKIN CALCIFICATION; SYSTEMIC SCLEROSIS;

ADULT; BIOPSY; FEMALE; FOREARM; GLUCOSE TRANSPORTER TYPE 1; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; SCLERODERMA, SYSTEMIC; SKIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 30744438818     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2005.10.007     Document Type: Article

References (44)

1. W.L. Norton, E.R. Hurd, D.C. Lewis, and M. Ziff Evidence of microvascular injury in scleroderma and systemic lupus erythematosus: quantitative study of the microvascular bed J Lab Clin Med 71 1968 919 933
2. R. Fleischmajer, and J.S. Perlish Capillary alterations in scleroderma J Am Acad Dermatol 2 1980 161 170
3. H.R. Maricq, E.C. LeRoy, and W.A. D'Angelo Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders Arthritis Rheum 23 1980 183 189
4. M.I. Jayson Systemic sclerosis: a collagen or microvascular disease? BMJ 288 1984 1855 1857
5. A.J. Freemont, J. Hoyland, P. Fielding, N. Hodson, and M.I. Jayson Studies of the microvascular endothelium in uninvolved skin of patients with systemic sclerosis: direct evidence for a generalized microangiopathy Br J Dermatol 126 1992 561 568
6. R.J. Prescott, A.J. Freemont, C.J. Jones, J. Hoyland, and P. Fielding Sequential dermal microvascular and perivascular changes in the development of scleroderma J Pathol 166 1992 255 263
7. R. Sgonc, M.S. Gruschwitz, H. Dietrich, H. Recheis, M.E. Gershwin, and G. Wick Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma J Clin Invest 98 1996 785 792
8. M. Bukhari, S. Hollis, T. Moore, M.I. Jayson, and A.L. Herrick Quantitation of microcirculatory abnormalities in patients with primary Raynaud's phenomenon and systemic sclerosis by video capillaroscopy Rheumatology 39 2000 506 512
9. R.H. Wenger, and M. Gassmann Oxygen(es) and the hypoxia-inducible factor-1 Biol Chem 378 1997 609 616
10. D.V. Faller Endothelial cell responses to hypoxic stress Clin Exp Pharmacol Physiol 26 1999 74 84
11. T. Sanchez-Elsner, L.M. Botella, B. Velasco, A. Corbi, L. Attisano, and C. Bernabeu Synergistic cooperation between hypoxia and transforming growth factor-beta pathways on human vascular endothelial growth factor gene expression J Biol Chem 276 2001 38527 38535
12. G. Neufeld, T. Cohen, S. Gengrinovitch, and Z. Poltorak Vascular endothelial growth factor (VEGF) and its receptors FASEB J 13 1999 9 22
13. G. Neufeld, O. Kessler, and Y. Herzog The interaction of neuropilin-1 and neuropilin-2 with tyrosine-kinase receptors for VEGF Adv Exp Med Biol 515 2002 81 90
14. S. Rafii, D. Lyden, R. Benezra, K. Hattori, and B. Heissig Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy? Nat Rev Cancer 2 2002 826 835
15. N. Ferrara, H.P. Gerber, and J. LeCouter The biology of VEGF and its receptors Nat Med 9 2003 669 676
16. E.C. LeRoy, C. Black, and R. Fleischmajer Scleroderma (systemic sclerosis): classification, subsets and pathogenesis J Rheumatol 15 1988 202 205
17. K. Kikuchi, M. Kubo, T. Kadono, N. Yazawa, H. Ihn, and K. Tamaki Serum concentrations of vascular endothelial growth factor in collagen diseases Br J Dermatol 139 1998 1049 1051
18. O. Distler, A. Del Rosso, and R. Giacomelli Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers Arthritis Res 4 2002 R11
19. J.J. Choi, D.J. Min, and M.L. Cho Elevated vascular endothelial growth factor in systemic sclerosis J Rheumatol 30 2003 1529 1533
20. J. Viac, D. Schmitt, and A. Claudy Plasma vascular endothelial growth factor levels in scleroderma are not correlated with disease activity Acta Derm Venereol 80 2000 383
21. S. Clark, F. Campbell, T. Moore, M.I. Jayson, T.A. King, and A.L. Herrick Laser Doppler imaging-a new technique for quantifying microcirculatory flow in patients with primary Raynaud's phenomenon and systemic sclerosis Microvasc Res 57 1999 284 291
22. L.P. Robertson, R.W. Marshall, and P. Hickling Treatment of cutaneous calcinosis in limited systemic sclerosis with minocycline Ann Rheum Dis 62 2003 267 269
23. F.M. Wigley, R.A. Wise, R. Miller, B.W. Needleman, and R.J. Spence Anticentromere antibody as a predictor of digital ischemic loss in patients with systemic sclerosis Arthritis Rheum 35 1992 688 693
24. A.L. Herrick, M. Heaney, S. Hollis, and M.I. Jayson Anticardiolipin, anticentromere and anti-Scl-70 antibodies in patients with systemic sclerosis and severe digital ischaemia Ann Rheum Dis 53 1994 540 542
25. V.D. Steen, G.L. Ziegler, G.P. Rodnan, and T.A. Medsger Clinical and laboratory associations of anticentromere antibody in patients with progressive systemic sclerosis Arthritis Rheum 27 1984 125 131
26. M. Vayssairat, D. Hidouche, N. Abdoucheli-Baudot, and J.P. Gaitz Clinical significance of subcutaneous calcinosis in patients with systemic sclerosis. Does diltiazem induce its regression? Ann Rheum Dis 57 1998 252 254
27. A.V. Ramanan, and B.M. Feldman Clinical outcomes in juvenile dermatomyositis Curr Opin Rheumatol 14 2002 658 662
28. D. Ramonet, M. Pugliese, and M.J. Rodriguez Calcium precipitation in acute and chronic brain diseases J Physiol 96 2002 307 312
29. L.P. Re, and R.P. Karzel Management of rotator cuff calcifications Orthop Clin North Am 24 1993 125 132
30. Y.M. Lee, C.H. Jeong, and S.Y. Koo Determination of hypoxic region by hypoxia marker in developing mouse embryos in vivo: a possible signal for vessel development Dev Dyn 220 2001 175 186
31. R. Airley, J. Loncaster, and S. Davidson Glucose transporter glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix Clin Cancer Res 7 2001 928 934
32. R.E. Airley, J. Loncaster, and J.A. Raleigh GLUT-1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: relationship to pimonidazole binding Int J Cancer 104 2003 85 91
33. R. Gherzi, G. Melioli, and M. de Luca "HepG2/erythroid/brain" type glucose transporter (GLUT1) is highly expressed in human epidermis: keratinocyte differentiation affects GLUT1 levels in reconstituted epidermis J Cell Physiol 150 1992 463 474
34. C. Ballaun, W. Weninger, A. Uthman, H. Weich, and E. Tschachler Human keratinocytes express the three major splice forms of vascular endothelial growth factor J Invest Dermatol 104 1995 7 10
35. M. Detmar, L.F. Brown, and B. Berse Hypoxia regulates the expression of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptors in human skin J Invest Dermatol 108 1997 263 268
36. J. Viac, S. Palacio, D. Schmitt, and A. Claudy Expression of vascular endothelial growth factor in normal epidermis, epithelial tumors and cultured keratinocytes Arch Dermatol Res 289 1997 158 163
37. M. Voldstedlund, and E. Dabelsteen Expression of GLUT1 in stratified squamous epithelia and oral carcinoma from humans and rats APMIS 105 1997 537 545
38. V.S. Rajkumar, C. Sundberg, D.J. Abraham, K. Rubin, and C.M. Black Activation of microvascular pericytes in autoimmune Raynaud's phenomenon and systemic sclerosis Arthritis Rheum 42 1999 930 941
39. P. Helmbold, E. Fiedler, M. Fischer, and W.C. Marsch Hyperplasia of dermal microvascular pericytes in scleroderma J Cutan Pathol 31 2004 431 440
40. C. Sundberg, M. Ivarsson, B. Gerdin, and K. Rubin Pericytes as collagen-producing cells in excessive dermal scarring Lab Invest 74 1996 452 466
41. V.M. Kahari, M. Sandberg, H. Kalimo, T. Vuorio, and E. Vuorio Identification of fibroblasts responsible for increased collagen production in localized scleroderma by in situ hybridization J Invest Dermatol 90 1988 664 670
42. Z. Mackiewicz, A. Sukura, and D. Povilenaite Increased but imbalanced expression of VEGF and its receptors has no positive effect on angiogenesis in systemic sclerosis skin Clin Exp Rheumatol 20 2002 641 646
43. O. Distler, A. Scheid, and J. Rethage Hypoxia-induced overexpression of vascular endothelial growth factor (VEGF) in systemic sclerosis (SSc) fails to induce angiogenesis in vivo Arthritis Rheum 44 2002 113
44. O. Distler, J.H.W. Distler, and A. Scheid Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosis Circ Res 95 2004 109 116